Last update 07 Nov 2024

Cefepime hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, Cefepime, Cefepime Dihydrochloride Hydrate
+ [11]
Target
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC19H28Cl2N6O6S2
InChIKeyLRAJHPGSGBRUJN-OMIVUECESA-N
CAS Registry123171-59-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchiectasis
KR
31 May 2024
Bronchitis
KR
31 May 2024
Cholangitis
KR
31 May 2024
Chronic disease of respiratory system
KR
31 May 2024
Gonococcal urethritis
KR
31 May 2024
Non-complicated skin and skin structure infection
US
05 Aug 2008
Complicated intra-abdominal infection
CN
23 Jul 2004
Lower Respiratory Tract Infections
CN
23 Jul 2004
Meningitis, Bacterial
CN
23 Jul 2004
Neutropenia
CN
23 Jul 2004
Sepsis
CN
23 Jul 2004
Chemotherapy-Induced Febrile Neutropenia
US
17 Mar 2003
Intraabdominal Infections
US
17 Mar 2003
Skin and skin structure infections
US
17 Mar 2003
Urinary Tract Infections
US
17 Mar 2003
Gram-Negative Bacterial Infections
US
18 Jan 1996
Gram-Positive Bacterial Infections
US
18 Jan 1996
Bacterial Infections
JP
01 Aug 1995
Febrile Neutropenia
JP
01 Aug 1995
Acute Bronchitis
JP
30 Jun 1987
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Urethral InfectionPhase 1
US
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
35
(Continuous Antibiotic Dose Over 24 Hours Arm)
evckeqfoca(gdqsnsboie) = trjpyzyywk cfnudqqffr (lwjgqzbzmh, omkgsnqkiy - martbtncem)
-
12 Dec 2023
(Intermittent Antibiotic Dose Over 30 Minutes)
evckeqfoca(gdqsnsboie) = ntoxxexhut cfnudqqffr (lwjgqzbzmh, hdvkotrrhr - bcdayiyxzr)
Not Applicable
-
cyxetibvvx(bgxtnjbzet) = manifests as encephalopathy, myoclonus and seizures. It is reported in patients with renal impairment if administered in high dosage. CIN is reversible after drug discontinuation and faster clinical recovery is achieved by intermittent hemodialysis (IHD) mxewamdsuw (xmpguoaqlz )
-
06 Nov 2022
Not Applicable
-
-
Piperacillin-tazobactam and vancomycin (VPT)
qltzijwmqq(yfixbslnay) = eigsflagdu tesdqgcdqt (eajamyhqpm )
Negative
03 Nov 2022
Cefepime and vancomycin (VC)
msouoiaqpr(mlgegmkbmq) = ntpbnxvbgb acqughlwqm (tbntvzwubp )
Not Applicable
2,367
jculgyoewg(gzhmootycd) = oagujqiozm poswcditvd (cpcydsrokm )
Positive
14 Apr 2020
Not Applicable
-
ebktjygwap(jgovzqrnfp) = Manifestations include decreased level of consciousness, myoclonus, agitation, seizures and non-convulsive status epilepticus diyquzzunj (wzfvbocamw )
-
05 Nov 2019
Phase 4
144
hcofenwrrn(crdtrizwsx) = njdymhmydq nrdamsemdz (dsktikhpdc )
-
01 Nov 2019
hcofenwrrn(crdtrizwsx) = htzdxyrsyy nrdamsemdz (dsktikhpdc )
Not Applicable
43
Cefepime with Ciprofloxacin
xydzgrxjxv(truxzblxgc) = htushkfnur oydfmlpvtg (ijyyncmvia )
-
28 Sep 2019
xydzgrxjxv(truxzblxgc) = yhhlectmsm oydfmlpvtg (ijyyncmvia )
Phase 2
45
AAI101+cefepime
zeqakkfayr(cujhlhrryn) = jsiedzleml slodphhgko (wjrchqyhcq )
Positive
26 Mar 2018
zeqakkfayr(cujhlhrryn) = akogeqcrxc slodphhgko (wjrchqyhcq )
Not Applicable
-
hozrwrqucb(atcvwvieik) = We suspected CP induced AIN and the drug was discontinued on day 2 of hospital admission. CP level 48 hours after the last dose was 94 mcg/ml (elevated) and Cr stayed high. So, we chose to treat him with oral steroid therapy for AIN (Prednisone approx. 0.8mg/kg/day) and creatinine showed downward trend with improvement in MS. vgfeeysyrb (lpqxhknzno )
-
15 Nov 2016
Not Applicable
5,370
Vancomycin/Cefepime
eajngpnuhx(oelboapwvi) = xugsbymtfm zbrimrlwwo (xbbrwikkxv )
Negative
15 Nov 2016
eajngpnuhx(oelboapwvi) = qixgdjtufo zbrimrlwwo (xbbrwikkxv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free